Navigation Links
ISU plant pathologist updates science community on groundbreaking research
Date:10/11/2011

AMES, Iowa In the two years since Iowa State University's Adam Bogdanove, along with student Matthew Moscou, published their groundbreaking gene research in the cover story of the journal Science, researchers around the world have built on those findings to explore further breakthroughs.

Science has published another article by Bogdanove in the Sept. 30 issue that updates the scientific community on where the research has been since 2009 and where it is heading.

"In the past two years, an extraordinary number of things have happened in this field," said Bogdanove, a professor of plant pathology. "This is really pretty revolutionary."

Bogdanove's research published in 2009 uncovered how so-called TAL (Transcription Activator-like) effector proteins bind to different DNA locations, and how particular amino acids in each protein determine those locations -- called binding sites -- in a very straightforward way.

Knowing this, scientists are using the proteins to target and manipulate specific genes, something that was much more difficult to accomplish prior to this research.

That could lead to breakthroughs in understanding gene function and improving traits in livestock and plants, and even treating human genetic disorders, according to Bogdanove.

Bogdanove says in the two years since his and Moscou's work was published, nearly two dozen research papers have been published using this discovery.

"We are so excited about the potential of these proteins. Just in the past six months they have been used successfully in model organisms such as yeast, zebrafish, and C. elegans (a type of worm used to study development), and even in human stem cells. There is some really innovative stuff going on," he said.

Model organisms are used to understand particular biological functions.

Bogdanove collaborated on this Science article with Dan Voytas, a former member of the Iowa State University faculty and now director of the Center for Genome Engineering at the University of Minnesota.

Bogdanove cautions in the article that the power of the technologies based on TAL effectors raises legal, sociological and ethical questions about how their use should be regulated, but says that it may be just a matter of a few years before these proteins see real application in areas such as crop improvement and human medicine.


'/>"/>

Contact: Adam Bogdanove
ajbog@iastate.edu
515-294-3421
Iowa State University
Source:Eurekalert  

Related biology news :

1. Danforth Plant Science Center awarded major bioenergy grant from US Department of Energy
2. Pragues 88 nature reserves threatened by invasive plant species
3. Seed time-capsule will aid study of plant evolution amid environmental change
4. Breakthrough: A robot brain implanted in a rodent
5. Productivity of land plants may be greater than previously thought
6. New approach challenges old ideas about plant species and biomass
7. Amateur botanists discover a genuflecting plant in Brazil
8. ASPB convenes leaders to chart future of plant science research
9. Scientists solve long-standing plant biochemistry mystery
10. Restoring forests and planting trees on farms can greatly improve food security
11. Small bowel transplant, Crohns experts from around the world hosted by Georgetown
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ISU plant pathologist updates science community on groundbreaking research
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... , its innovative, highly flexible and award winning eClinical ... customers. iMedNet is a proven Software-as-a-Service (SaaS) ... Data Capture (EDC), but also delivers an entire suite ...
(Date:2/3/2017)... -- A new independent identity strategy consultancy firm announces ... Designed to fill a critical niche in technical and ... Mark Crego and Janice Kephart ... expertise that span federal governments, the 9/11 Commission, private ... expertise has a common theme born from a shared ...
(Date:1/31/2017)...  Spero Therapeutics, LLC, a biopharmaceutical company founded ... bacterial infections, today announced it has acquired a ... Bono Bio Ltd (PBB) to bolster its pipeline ... of Gram-negative bacteria.   The assets acquired have been ... group company. "The acquisition of these ...
Breaking Biology News(10 mins):
(Date:2/25/2017)... ... February 25, 2017 , ... ... Trials in an ongoing effort to create meaningful change by increasing communication, ... research with emphasis on consumers and patients’ mental health well-being. , Both organizations ...
(Date:2/24/2017)... ... February 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company ... National Institute of Mental Health (NIMH) for the further advancement of the company’s 3-month ... technology and is expected to deliver therapeutic levels of olanzapine for a period of ...
(Date:2/24/2017)... 24, 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: ... a clinical-stage oncology and dermatology biopharmaceutical company, today ... participate in its previously announced rights offering of ... of common stock and Series C Convertible Preferred ... warrants. As previously announced, the ...
(Date:2/24/2017)... Symic Bio, a biopharmaceutical company focused on ... therapeutics, announced today the completion of enrollment for the ... The trial will evaluate the safety and efficacy of ... of restenosis following angioplasty. "We,re pleased ... said Nathan Bachtell , M.D., Chief Medical Officer ...
Breaking Biology Technology: